ACME UNITED CORP (ACU)
Health Care · Office Supplies & Emergency Medical Products · NYSE American
Acme United is a global provider of cutting, measuring, and first aid products for schools, offices, and industrial users, bolstered by a direct-to-consumer emergency response segment.
What ACME UNITED CORP does
Acme United Corporation is a supplier of cutting, measuring, and first aid products to the school, home, office, and industrial markets. The company owns several brands, including Westcott, which focuses on cutting tools and office supplies, and various first aid and emergency response lines, recently expanded through the acquisition of My Medic. Its operations are organized into U.S., Canadian, and European segments.
Recent developments
On January 15, 2026, the company acquired the assets of My Medic, a direct-to-consumer business selling tactical, trauma, and emergency response products. On July 15, 2026, the company entered into a new $65 million syndicated credit facility expiring in 2029.
From ACME UNITED CORP's filing of 2026-08-06.
Themes: back-to-school seasonals, first aid / emergency response, e-commerce, direct-to-consumer (DTC), industrial supplies
Fundamentals
- Price$61.94 as of 2026-10-08 close
- Market cap$237M as of 2026-08-01 (share count; price 2026-10-08)
- 1-year return+56.9% 2025-10-08 close $39.47 → 2026-10-08 close $61.94
- P/E26.09 as of 2026-10-08
- Net margin+5.2% FY2025, SEC XBRL
- Gross margin+39.4% FY2025, SEC XBRL
- ROE+8.7% FY2025, SEC XBRL
- Debt / equity0.27 as of 2026-09-03
- Revenue growth (YoY)+9.0% as of 2026-09-03
- Revenue CAGR (3y)+0.4% SEC XBRL
- Beta0.50 as of 2026-09-03
- Last reported earnings2026-07-23 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.0%; at least 2 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How ACU compares in its sector
- price-to-earnings ratiomiddle range 185 covered Health Care peers, as of 2026-10-08
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-03
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-03
- gross marginbottom 25% 189 covered Health Care peers, as of 2026-09-03
- return on equitymiddle range 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- indicated dividend yieldmiddle range 72 covered Health Care peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, ACU's dividend was covered by reported results (earnings payout 23%, free-cash-flow payout 31%). This describes past coverage, not a forecast.
- Earnings payout23% dividends / net income
- Free-cash-flow payout31% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How ACME UNITED CORP looks technically
ACME UNITED CORP (ACU) is trading 27.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 172 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 26, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 49, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 26 trading days ago. It is 4.5% below its all-time high.
Trend
8
| Distance from the 200-day | it is trading 27.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +27.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $61.18 | $61.18 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $48.47 | $48.47 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 9 calendar days ago — the swings before that are what the structure reading is measured on | 9 sessions |
| Wave structure | its recent swings can be read as a completed three-part upward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes above 64.87. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave upward correction, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 172 trading days ago — a "golden cross", a bullish long-term signal | 172 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 26, with buyers in control | 25.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 49, neither overbought (above 70) nor oversold (below 30) | 48.7 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($61.35 to $64.87) — its "stochastic" reading is 17 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 16.8 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 33 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $64.87 | $64.87 |
|---|---|---|
| From the 52-week high | it is 4.5% below its 52-week high (its highest price of the past year) | -4.5% |
| Above the 52-week low | it is 74.5% above its 52-week low (its lowest price of the past year) | +74.5% |
| Below the 52-week high | it is 4.5% below its highest point of the past year | 4.5% |
| Since a 20-day breakout | it made a new 20-day high about 26 trading days ago | 26 sessions |
| Since a 55-day breakout | it made a new 55-day high about 26 trading days ago | 26 sessions |
| All-time high | its highest closing price on record is $64.87 (set on 2026-09-29) | $64.87 |
| Given back of the 52-week move | over the past year its closes ranged ($35.50 to $63.82), and it has given back only a small part of its rise from last year’s low — 7% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $45.41 to $46.32. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 6.6% |
| From the all-time high | it is 4.5% below its all-time high | -4.5% |
| Nearest price level | it is trading 2.9% below a resistance level at $63.75 — a price it turned at three times since 2026-08-19, most recently on 2026-09-17. Since 2024-10-08 it has 10 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +2.9% |
| All-time low | its lowest closing price on record is $0.8125 (set on 1999-12-16) | $0.8125 |
| Above the all-time low | it is 7523.4% above its all-time low | +7,523% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 76% of it) | 24th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.71 between its high and its low — about 2.8% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.71 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $60.50 and $64.52 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $60.50 – $62.51 – $64.52 |
| Typical daily range (% of price) | its price moves about 2.8% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.8% |
| Stretch from the 200-day average | it is trading 7.9 daily ranges above its 200-day average price (27.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 7.9 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.18× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-10-08 0.5% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.5% |
|---|---|---|
| Open gap | it gapped 3.9% above the previous close 52 sessions ago and has not traded back through the level it left behind at 52.45 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +3.9% |
Price streaks
1
| Closing streak | it has closed lower 3 sessions in a row, a -2.76% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 3 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 0.3 percentage points (the stock gained 1.3% while the market gained 1.0%) | +0.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 25.8 percentage points (the stock gained 29.6% while the market gained 3.8%) | +25.8% |
| vs market, 6 months | over the past 6 months this stock beat the market by 21.9 percentage points (the stock gained 39.4% while the market gained 17.5%) | +21.9% |
| vs market, 12 months | over the past 12 months this stock beat the market by 42.0 percentage points (the stock gained 56.9% while the market gained 15.0%) | +42.0% |
Signal agreement
2
| Bullish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a strong uptrend, with buyers in control, outperforming the market over 6 months, near the bottom of its 14-day range (oversold), trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 1.9% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thick, spanning 10.9% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | +1.9% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 18% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $52.42 — a volume-weighted average of daily closes over 192 sessions, not a true tick-by-tick VWAP. | +18.1% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% above the average price paid since it last reported on 2026-07-23 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $60.90 — a volume-weighted average of daily closes over 54 sessions, not a true tick-by-tick VWAP. | +1.7% |
Price levels it has turned at before
ACU last closed at $61.94 on 2026-10-08. Since 2024-10-08 it has turned at 10 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $63.75 | Resistance | 2.9% above the last close | turned there three times · 2026-08-19 to 2026-09-17 |
| $59.91 | Support | 3.3% below the last close | turned there twice · 2026-07-29 to 2026-09-15 |
| $46.97 | Support | 24.2% below the last close | turned there three times · 2026-02-26 to 2026-04-22 |
| $45.03 | Support | 27.3% below the last close | turned there 8 times · 2024-10-15 to 2026-07-22 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part upward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes above $64.87.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This reading has stood for 7 trading days, since 2026-09-30.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · in a strong, established uptrend (ADX) · Near the all-time high · beating the market · Stretched far above its 200-day average (6+ daily ranges) · At the bottom of its 14-day range (stochastic below 20) | Learn: moving average · golden cross · adx · rsi · breakout · all time high
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$58.00 range $58.00 – $58.00
Analyst estimates, as of 2026-10-06. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Key risks (from latest filing)
["impact of international trade policies and tariffs on product costs and supply chain","risks related to business acquisitions and their successful integration","volatility in global economic conditions and consumer spending habits"]
What changed in the latest 10-Q
AI-assisted comparison of ACU's 10-Q filed 2026-08-06 against the prior one filed 2026-05-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-06) reports net sales for the three months ended June 30, 2026 of $62,716,000 compared to $53,996,000 in the same period in 2025, an increase of 16%.
- Newer filing (2026-08-06) reports net sales for the six months ended June 30, 2026 of $115,017,000 compared to $99,954,000 in the same period in 2025, an increase of 15%.
- Newer filing (2026-08-06) states that excluding incremental sales from the My Medic acquisition, sales increased 8% and 7% for the three and six months ended June 30, 2026, respectively, compared to the same periods in 2025.
- Newer filing (2026-08-06) states U.S. net sales for the three months ended June 30, 2026 increased 17% and for the six months increased 15% compared to the same periods in 2025, due to strong sales across all product lines and My Medic contribution.
- Newer filing (2026-08-06) reports Canada net sales for the three months ended June 30, 2026 increased 1% in U.S. dollars and 3% in local currency, and for the six months increased 7% in U.S. dollars and 6% in local currency, due to higher sales of first aid products.
- Newer filing (2026-08-06) reports European net sales for the three months ended June 30, 2026 increased 24% in U.S. dollars and 19% in local currency, and for the six months increased 28% in U.S. dollars and 19% in local currency, due primarily to higher ecommerce sales and contribution from the cutting and sharpening products acquired October 1, 2025.
- Newer filing (2026-08-06) reports gross profit for the three months ended June 30, 2026 of $26,688,000 (42.6% of net sales) compared to $22,149,000 (41.0% of net sales) in 2025, and for the six months of $47,473,000 (41.3%) compared to $40,066,000 (40.1%), with increases primarily due to the My Medic direct-to-consumer business.
- Newer filing (2026-08-06) reports SG&A expenses for the three and six months ended June 30, 2026 of $19,858,000 (31.7%) and $38,899,000 (33.8%), with increases primarily due to the My Medic acquisition and higher personnel expenses.
- Newer filing (2026-08-06) adds explanation that the increase in SG&A expenses as a percentage of sales was due to higher advertising needed for the direct-to-consumer My Medic business.
- Newer filing (2026-08-06) reports operating income for the three months ended June 30, 2026 of $6,830,000 compared to $6,390,000 in 2025, and for the six months of $8,574,000 compared to $8,816,000 in 2025, with the six-month decrease primarily due to higher cost of sales.
- Newer filing (2026-08-06) states U.S. segment operating income decreased by $24,000 for the three months ended June 30, 2026 compared to the same period in 2025.
- Removed:
- Older filing (2026-05-06) reports net sales for the three months ended March 31, 2026 of $52,301,000 compared to $45,958,000 in the same period in 2025, an increase of 14%.
- Older filing (2026-05-06) states that excluding My Medic acquisition incremental sales, comparable sales increased 6% for the three months ended March 31, 2026.
- Older filing (2026-05-06) states U.S. net sales for the three months ended March 31, 2026 increased 12%, primarily due to increased sales of first aid and medical products and My Medic acquisition.
- Older filing (2026-05-06) reports Canada net sales for the three months ended March 31, 2026 increased 16% in U.S. dollars and 11% in local currency due to higher sales of first aid products.
- Older filing (2026-05-06) reports European net sales for the three months ended March 31, 2026 increased 32% in U.S. dollars and 19% in local currency.
- Older filing (2026-05-06) reports gross profit for the three months ended March 31, 2026 of $20,785,000 (39.7% of net sales) compared to $17,917,000 (39.0% of net sales) in 2025.
- Older filing (2026-05-06) reports SG&A expenses for the three months ended March 31, 2026 of $19,039,000 (36.4% of net sales) compared with $15,491,000 (33.7% of net sales) in 2025, an increase of $3,548,000.
- Older filing (2026-05-06) reports operating income for the three months ended March 31, 2026 of $1,746,000 compared with $2,426,000 in the same period of 2025.
- Older filing (2026-05-06) states U.S. segment operating income decreased by $1,320,000 for the three months ended March 31, 2026, primarily due to higher cost of sales and increased operating expenses from tariff-related costs, quality assurance investments at Med-Nap, and rising employee healthcare expenses.
- Older filing (2026-05-06) states Canadian segment operating income increased by $206,000 for the three months ended March 31, 2026, primarily due to higher sales of first aid products.
- Older filing (2026-05-06) states European segment operating income increased by $434,000 for the three months ended March 31, 2026, primarily due to higher sales.
- Older filing (2026-05-06) reports interest expense, net of $486,000 for the three months ended March 31, 2026 compared with $397,000 in 2025, an $89,000 increase from higher average outstanding borrowings partially offset by lower average interest rates.
- Older filing (2026-05-06) reports other expense, net of $16,000 for the three months ended March 31, 2026 compared to other income of $90,000 in 2025.
- Older filing (2026-05-06) reports effective income tax rate of 21% for the three months ended March 31, 2026 compared to 22% in 2025.
- Reworded:
- Newer filing (2026-08-06) reorders the risk factor list: inflation and currency fluctuation moved from items (v) and (ix) in the older filing to items (iv) and (v), respectively; wars in Ukraine and the Middle East moved from item (iv) to item (vi).
- Newer filing (2026-08-06) rephrases war risk factor from "wars in Iran and elsewhere in the Middle East and Ukraine" (older) to "wars in Ukraine and the Middle East" (newer).
- Notes:
- The newer filing text appears truncated at "Operating income in the U.S. segment decreased by" and the older filing text appears truncated at "During the first three months of 2026, working capital increased approximately"; portions of MD&A beyond these points could not be compared.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 11 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-040 buys · 11 sells ($2M) — 3 selling insiders
- Last 180 days · read to 2026-10-040 buys · 12 sells ($2M) — 3 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-18. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ACU's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding ACU as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 333,526
- Reported value $15,915,885
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 2 increased, 2 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ACU's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ACU had 71,385 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
ACU had 1.86% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 1.66 days to cover at the same settlement.
- Reported short interest (shares) 71,385
- Short interest (% of shares outstanding) 1.86%
- Prior settlement (shares) 74,628
- Reported change -4.35%
- Days to cover (reported) 1.66
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- 3M Company (MMM)
- Avery Dennison (AVY)
- Newell Brands (NWL)
- Fiskars Group
- Essity AB
- Johnson & Johnson (JNJ)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ACU vs…
ACME UNITED CORP is found in…
Frequently asked questions
What does ACME UNITED CORP (ACU) do?
Acme United Corporation is a supplier of cutting, measuring, and first aid products to the school, home, office, and industrial markets. The company owns several brands, including Westcott, which focuses on cutting tools and office supplies, and various first aid and emergency response lines, recently expanded through the acquisition of My Medic. Its operations are organized into U.S., Canadian, and European segments.
What sector is ACME UNITED CORP (ACU) in?
ACME UNITED CORP (ACU) is classified in the Health Care sector. Its industry is Office Supplies & Emergency Medical Products. It trades on NYSE American.
Does ACU pay a dividend?
Yes — ACME UNITED CORP (ACU) pays a dividend, with an indicated yield of about 1.04% and at least 2 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-03). Informational only — not financial advice.
Who are ACME UNITED CORP's (ACU) competitors?
Notable peers of ACME UNITED CORP (ACU) include 3M Company, Avery Dennison, Newell Brands, Fiskars Group and Essity AB. This peer set is informational only — not financial advice.
Is ACME UNITED CORP (ACU) overbought or oversold right now?
ACME UNITED CORP (ACU) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 49, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ACU come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.